Literature DB >> 20338153

Structural approach to the aging of phosphylated cholinesterases.

Patrick Masson1, Florian Nachon, Oksana Lockridge.   

Abstract

Phosphylated cholinesterases (ChE) can undergo a side reaction that progressively decreases their reactivatability. This process, termed "aging", results from dealkylation of the adduct and depends on the structure of the organophosphyl moiety. Aged ChEs are resistant to reactivation by oximes. Owing to the toxicological importance of OPs, the molecular mechanism of aging has been the subject of research for decades. It was not clear whether aging involves the same bond breakage regardless the type of OP or is a scission of P-O-C bonds (P-O or O-C) in phosphates/phosphonates, P-N-C bonds in phosphoramidates, and P-S-C bonds in phosphonothionates. It was assumed that the resulting negatively charged atom on phosphorus of the aged adduct prevented nucleophilic attack by oximates, but studies on negatively charged model molecules do not support this hypothesis. Decrease in conformational flexibility of aged enzymes may contribute to their non-reactivatability by preventing proper adjustment of reactivators in the active site gorge. MALDI-TOF mass spectrometry of phosphylated human butyrylcholinesterase (hBChE) in water and in (18)O-water provided evidence that aging results from O-C breakage, i.e. O-dealkylation. In contrast, the isomalathion-BChE conjugate ages mostly through P-S bond cleavage, but a minor product results from O-C and/or S-C breakage. The crystal structures of hBChE and hAChE inhibited by tabun showed that aging of tabun-ChE conjugates results from O-dealkylation. However, depending on the nature of O-alkyl and N-alkyl chains, aging of BChE inhibited by other phosphoramidates results either from O-C breakage or deamination, i.e. P-N breakage. It was found that dealkylation of branched alkoxy involves a transient carbocation. Dealkylation of OP-ChE conjugates is accompanied by enzyme conformational changes. Urea, organic solvent, heat and pressure denaturation of human BChE showed that the conformational stability of aged OP-BChE conjugates is dramatically increased compared to native enzyme. Determination of the three-dimensional structure of BChE and AChE conjugated to different OPs showed that aged adducts form a salt bridge with the protonated catalytic histidine. Structure alteration of aged enzymes is accompanied by exit of water molecules from the enzyme's active site gorge. In addition, neutron scattering studies provided evidence that the structural dynamics of aged BChE is dramatically altered compared to native enzyme. Knowledge of the molecular basis of aging will help to design reactivators of aged ChEs, molecules capable of slowing the aging process, and pseudocatalytic ChE-based bioscavengers. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20338153     DOI: 10.1016/j.cbi.2010.03.027

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  16 in total

Review 1.  Protein adducts as biomarkers of exposure to organophosphorus compounds.

Authors:  Judit Marsillach; Lucio G Costa; Clement E Furlong
Journal:  Toxicology       Date:  2012-12-20       Impact factor: 4.221

2.  Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.

Authors:  I Mangas; P Taylor; E Vilanova; J Estévez; T C C França; E Komives; Z Radić
Journal:  Arch Toxicol       Date:  2015-03-06       Impact factor: 5.153

3.  Kinetic assessment of N-methyl-2-methoxypyridinium species as phosphonate anion methylating agents.

Authors:  Joseph J Topczewski; Daniel M Quinn
Journal:  Org Lett       Date:  2013-02-14       Impact factor: 6.005

4.  Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic V-agents.

Authors:  Marielle Wandhammer; Eugénie Carletti; Marcel Van der Schans; Emilie Gillon; Yvain Nicolet; Patrick Masson; Maurice Goeldner; Daan Noort; Florian Nachon
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

5.  Aging mechanism of soman inhibited acetylcholinesterase.

Authors:  Gulseher Sarah Sirin; Yanzi Zhou; Lee Lior-Hoffmann; Shenglong Wang; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2012-09-28       Impact factor: 2.991

6.  Proteomic analysis of adducted butyrylcholinesterase for biomonitoring organophosphorus exposures.

Authors:  Judit Marsillach; Edward J Hsieh; Rebecca J Richter; Michael J MacCoss; Clement E Furlong
Journal:  Chem Biol Interact       Date:  2012-11-02       Impact factor: 5.192

7.  Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents.

Authors:  Sofya V Lushchekina; Lawrence M Schopfer; Bella L Grigorenko; Alexander V Nemukhin; Sergei D Varfolomeev; Oksana Lockridge; Patrick Masson
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

8.  A novel biosensor for the detection of organophosphorus (OP)-based pesticides using organophosphorus acid anhydrolase (OPAA)-FL variant.

Authors:  Monika Jain; Priyanka Yadav; Bhavana Joshi; Abhijeet Joshi; Prashant Kodgire
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-16       Impact factor: 4.813

9.  Design, synthesis, in silico studies and in vitro evaluation of isatin-pyridine oximes hybrids as novel acetylcholinesterase reactivators.

Authors:  Daniel A S Kitagawa; Rafael B Rodrigues; Thiago N Silva; Wellington V Dos Santos; Vinicius C V da Rocha; Joyce S F D de Almeida; Leandro B Bernardo; Taynara Carvalho-Silva; Cintia N Ferreira; Angelo A T da Silva; Alessandro B C Simas; Eugenie Nepovimova; Kamil Kuča; Tanos C C França; Samir F de A Cavalcante
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

10.  Development of organophosphate hydrolase activity in a bacterial homolog of human cholinesterase.

Authors:  Patricia M Legler; Susanne M Boisvert; Jaimee R Compton; Charles B Millard
Journal:  Front Chem       Date:  2014-07-16       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.